387 related articles for article (PubMed ID: 30550767)
21. Dysbiosis of Cervical and Vaginal Microbiota Associated With Cervical Intraepithelial Neoplasia.
Lin S; Zhang B; Lin Y; Lin Y; Zuo X
Front Cell Infect Microbiol; 2022; 12():767693. PubMed ID: 35237529
[TBL] [Abstract][Full Text] [Related]
22. Vaginal microbiota and personal risk factors associated with HPV status conversion-A new approach to reduce the risk of cervical cancer?
Yang Z; Zhang Y; Stubbe-Espejel A; Zhao Y; Liu M; Li J; Zhao Y; Tong G; Liu N; Qi L; Hutchins A; Lin S; Li Y
PLoS One; 2022; 17(8):e0270521. PubMed ID: 35944043
[TBL] [Abstract][Full Text] [Related]
23. Association of cervicovaginal dysbiosis mediated HPV infection with cervical intraepithelial neoplasia.
Kumari S; Bhor VM
Microb Pathog; 2021 Mar; 152():104780. PubMed ID: 33545325
[TBL] [Abstract][Full Text] [Related]
24. Vaginal Microbiome Dysbiosis is Associated with the Different Cervical Disease Status.
Ma Y; Li Y; Liu Y; Cao L; Han X; Gao S; Zhang C
J Microbiol; 2023 Apr; 61(4):423-432. PubMed ID: 37010797
[TBL] [Abstract][Full Text] [Related]
25. Correlation between the diversity of vaginal microbiota and the risk of high-risk human papillomavirus infection.
Chao XP; Sun TT; Wang S; Fan QB; Shi HH; Zhu L; Lang JH
Int J Gynecol Cancer; 2019 Jan; 29(1):28-34. PubMed ID: 30640680
[TBL] [Abstract][Full Text] [Related]
26. [Primary study on the relationship between high-risk HPV infection and vaginal cervical microbiota].
Zhang Z; Zhang D; Xiao BB; Zhang R; Bai HH; Dong HY; Bi H; Liu ZH
Zhonghua Fu Chan Ke Za Zhi; 2018 Jul; 53(7):471-480. PubMed ID: 30078257
[No Abstract] [Full Text] [Related]
27. Human papillomavirus and cervical cancer in the microbial world: exploring the vaginal microecology.
Zhang Z; Ma Q; Zhang L; Ma L; Wang D; Yang Y; Jia P; Wu Y; Wang F
Front Cell Infect Microbiol; 2024; 14():1325500. PubMed ID: 38333037
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of human papillomavirus among STD clinic attenders in Jamaica: association of younger age and increased sexual activity.
Figueroa JP; Ward E; Luthi TE; Vermund SH; Brathwaite AR; Burk RD
Sex Transm Dis; 1995; 22(2):114-8. PubMed ID: 7624812
[TBL] [Abstract][Full Text] [Related]
29. Clonal history of papillomavirus-induced dysplasia in the female lower genital tract.
Vinokurova S; Wentzensen N; Einenkel J; Klaes R; Ziegert C; Melsheimer P; Sartor H; Horn LC; Höckel M; von Knebel Doeberitz M
J Natl Cancer Inst; 2005 Dec; 97(24):1816-21. PubMed ID: 16368943
[TBL] [Abstract][Full Text] [Related]
30. Association of asymptomatic bacterial vaginosis with persistence of female genital human papillomavirus infection.
Kero K; Rautava J; Syrjänen K; Grenman S; Syrjänen S
Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2215-2219. PubMed ID: 28681204
[TBL] [Abstract][Full Text] [Related]
31. The global health impact of vaginal dysbiosis.
van de Wijgert JHHM; Jespers V
Res Microbiol; 2017; 168(9-10):859-864. PubMed ID: 28257809
[TBL] [Abstract][Full Text] [Related]
32. Human papilloma virus type 16 infection and the early onset of cervical cancer.
Karube A; Sasaki M; Tanaka H; Nakagome O; Dahiya R; Fujimoto S; Tanaka T
Biochem Biophys Res Commun; 2004 Oct; 323(2):621-4. PubMed ID: 15369795
[TBL] [Abstract][Full Text] [Related]
33. Chlamydia Trachomatis Infection-Associated Risk of Cervical Cancer: A Meta-Analysis.
Zhu H; Shen Z; Luo H; Zhang W; Zhu X
Medicine (Baltimore); 2016 Mar; 95(13):e3077. PubMed ID: 27043670
[TBL] [Abstract][Full Text] [Related]
34. Depiction of Vaginal Microbiota in Women With High-Risk Human Papillomavirus Infection.
Wei ZT; Chen HL; Wang CF; Yang GL; Han SM; Zhang SL
Front Public Health; 2020; 8():587298. PubMed ID: 33490017
[TBL] [Abstract][Full Text] [Related]
35. Human Papilloma Virus infection and cervical cancer among women who sell sex in Eastern and Southern Africa: A scoping review.
Macleod CI; Reynolds JH
Womens Health (Lond); 2021; 17():17455065211058349. PubMed ID: 34775848
[TBL] [Abstract][Full Text] [Related]
36. A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women.
Castle PE; Wacholder S; Lorincz AT; Scott DR; Sherman ME; Glass AG; Rush BB; Schussler JE; Schiffman M
J Natl Cancer Inst; 2002 Sep; 94(18):1406-14. PubMed ID: 12237286
[TBL] [Abstract][Full Text] [Related]
37. Human papillomavirus vaccine for genotypes 6, 11, 16 and 18: new drug. Cervical cancer prevention: high hopes...
Prescrire Int; 2007 Jun; 16(89):91-4. PubMed ID: 17582921
[TBL] [Abstract][Full Text] [Related]
38. Molecular characterization of lower vaginal swabs for Human papilloma virus in association with Chlamydia trachomatis infection in Cameroonian Women.
Fogue P; Djeudong G; Bouting G; Aglago E; Simo G; Lueong S
J Infect Public Health; 2018; 11(3):314-320. PubMed ID: 28919017
[TBL] [Abstract][Full Text] [Related]
39. Microbiome and Cervical Cancer.
Castanheira CP; Sallas ML; Nunes RAL; Lorenzi NPC; Termini L
Pathobiology; 2021; 88(2):187-197. PubMed ID: 33227782
[TBL] [Abstract][Full Text] [Related]
40. The interplay between human papillomavirus and vaginal microbiota in cervical cancer development.
Sharifian K; Shoja Z; Jalilvand S
Virol J; 2023 Apr; 20(1):73. PubMed ID: 37076931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
